Structural Analysis of Prion Proteins by Means of Drift Cell and Traveling Wave Ion Mobility Mass Spectrometry

Journal of the American Society for Mass Spectrometry

Volumn 21, Issue 5, 2010, Pages 845-854

  Hilton, Gillian R ^a   Thalassinos, Konstantinos ^a   Grabenauer, Megan ^b   Sanghera, Narinder ^a   Slade, Susan E ^a   Wyttenbach, Thomas ^b   Robinson, Philip J ^a   Pinheiro, Teresa J T ^a   Bowers, Michael T ^b   Scrivens, James H ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSOLUTE CROSS-SECTIONS; ACIDIC ENVIRONMENT; ARRIVAL-TIME DISTRIBUTIONS; DRIFT CELLS; GLYCOSYL; ION MOBILITY; ION MOBILITY-MASS SPECTROMETRY; ISOFORMS; LIFE SPAN; MASS-TO-CHARGE RATIO; MISFOLDING; MOLECULAR EVENTS; NEUTRAL PH; PHOSPHATIDYLINOSITOL; PRION DISEASE; PRION PROTEIN; PROTEIN ISOFORMS; RECOMBINANT PROTEIN; SCREENING ASSAYS; SECONDARY AND TERTIARY STRUCTURES; SELECTIVE SEPARATION; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; TRAVELING WAVE;

CELL MEMBRANES; CYTOLOGY; IONS; MASS SPECTROMETRY; SCANDIUM; STRUCTURAL ANALYSIS;

PROTEINS;

PRION PROTEIN;

ALPHA HELIX; ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ION MOBILITY SPECTROMETRY; PH; PRION DISEASE; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEPARATION TECHNIQUE; STRUCTURE ANALYSIS; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; HYDROGEN-ION CONCENTRATION; MESOCRICETUS; PRIONS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

MESOCRICETUS AURATUS;

EID: 77951203674     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2010.01.017     Document Type: Article

References (51)

1. Collinge J., Palmer M.S. Prion Diseases. Curr. Opin. Genet. Dev 1992, 2(3):448-454.
2. Prusiner S.B. Novel Proteinaceous Infectious Particles Cause Scrapie. Science 1982, 21(4542):136-144.
3. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(23):13363-13383.
4. Stahl N., Baldwin M.A., Teplow D.B., Hood L., Gibson B.W., Burlingame A.L., Prusiner S.B. Structural Studies of the Scrapie Prion Protein Using Mass Spectrometry and Amino Acid Sequencing. Biochemistry 1993, 32(8):1991-2002.
5. Riek R., Hornemann S., Wider G., Glockshuber R., Wuthrich K. NMR Characterization of the Full-Length Recombinant Murine Prion Protein, mPrP(23-231). FEBS Lett 1997, 413(2):282-288.
6. Donne D.G., Viles J.H., Groth D., Mehlhorn I., James T.L., Cohen F.E., Prusiner S.B., Wright P.E., Dyson H.J. Structure of the Recombinant Full-Length Hamster Prion Protein PrP(29-231): The N-Terminus is Highly Flexible. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(25):13452-13457.
7. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., Billeter M., Calzolai L., Wider G., Wuthrich K. NMR Solution Structure of the Human Prion Protein. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(1):145-150.
8. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E. Conversion of -Helices into -Sheets Features in the Formation of the Scrapie Prion Proteins. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(23):10962-10966.
9. Dabaghian R.H., Mortimer P.P., Clewley J.P. Prospects for the Development of Pre-Mortem Laboratory Diagnostic Tests for Creutzfeldt-Jakob Disease. Rev. Med. Virol 2004, 14(6):345-361.
10. Khamsi R. Prion Disease: The Shape of Things to Come. Nature 2006, 439(7073):134-135.
11. Brown, P.; Will, R. G.; Bradley, R.; Asher, D. M.; Detwiler, L. Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease: Background, Evolution, and Current Concerns. Emerg. Infect. Dis. 1001, 7(1), 616.
12. Collinge J. Variant Creutzfeldt-Jakob Disease. Lancet 1999, 354(9175):317-323.
13. Llewelyn C.A., Hewitt P.E., Knight R.S., Amar K., Cousens S., Mackenzie J., Will R.G. Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion. Lancet 2004, 363(9407):417-421.
14. Ironside J.W., Bishop M.T., Connolly K., Hegazy D., Lowrie S., Le Grice M., Ritchie D.L., McCardle L.M., Hilton D.A. Variant Creutzfeldt-Jakob Disease: Prion Protein Genotype Analysis of Positive Appendix Tissue Samples from a Retrospective Prevalence Study. BMJ 2006, 332(7551):1186-1188.
15. Peden A.H., Head M.W., Diane L.R., Jeanne E.B., James W.I. Preclinical vCJD after Blood Transfusion in a PRNP Codon 129 Heterozygous Patient. Lancet 2004, 364(9433):527-529.
16. Hilton D.A., Ghani A.C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D., Ironside J.W. Prevalence of Lymphoreticular Prion Protein Accumulation in UK Tissue Samples. J. Pathol 2004, 203(3):733-739.
17. Qin K., Yang Y., Mastrangelo P., Westaway D. Mapping Cu(II) Binding Sites in Prion Proteins by Diethyl Pyrocarbonate Modification and Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometric Footprinting. J. Biol. Chem 2002, 277(3):1981-1990.
18. Requena J.R., Groth D., Legname G., Stadtman E.R., Prusiner S.B., Levine R.L. Copper-Catalyzed Oxidation of the Recombinant SHa(29-231) Prion Protein. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(13):7170-7175.
19. Whittal R.M., Ball H.L., Cohen F.E., Burlingame A.L., Prusiner S.B., Baldwin M.A. Copper Binding to Octarepeat Peptides of the Prion Protein Monitored by Mass Spectrometry. Protein Sci 2000, 9:332-343. 2.
20. Onisko B., Dynin I., Requena J.R., Silva C.J., Erickson M., Carter J.M. Mass Spectrometric Detection of Attomole Amounts of the Prion Protein by nanoLC/MS/MS. J. Am. Soc. Mass Spectrom 2007, 18(6):1070-1079.
21. Back J.W., Sanz M.A., De Jong L., De Koning L.J., Nijtmans L.G., De Koster C.G., Grivell L.A., Van Der Spek H., Muijsers A.O. A Structure for the Yeast Prohibition Complex: Structure Prediction and Evidence from Chemical Crosslinking and Mass Spectrometry. Protein Sci 2002, 11(10):2471-2478.
22. Pushie M.J., Ross A.R., Vogel H.J. Mass Spectrometric Determination of the Coordination Geometry of Potential Copper(II) Surrogates for the Mammalian Prion Protein Octarepeat Region. Anal. Chem 2007, 79(15):5659-5667.
23. Maras B., Barra D., Schinina M.E., Cardone F., Pocchiari M. Prion (PrPres) Allotypes Profiling: New Perspectives from Mass Spectrometry. Eur. J. Mass Spectrom 2004, 10:371-382.
24. Principe S., Maras B., Schinina M.E., Pocchiari M., Cardone F. Unraveling the Details of Prion (con)Formation(s): Recent Advances by Mass Spectrometry. Curr. Opin. Drug Discov. Devel 2008, 11(5):697-707.
25. Wyttenbach T., Kemper P.R., Bowers M.T. Design of a New Electrospray Ion Mobility Mass Spectrometer. Int. J. Mass Spectrom 2001, 212(1/3):13-23.
26. Thalassinos K., Grabenauer M., Slade S.E., Hilton G.R., Bowers M.T., Scrivens J.H. Characterization of Phosphorylated Peptides Using Traveling Wave-Based and Drift Cell Ion Mobility Mass Spectrometry. Anal. Chem 2009, 81(1):248-254.
27. Mehlhorn I., Groth D., Stockel J., Moffat B., Reilly D., Yansura D., Willett W.S., Baldwin M., Fletterick R., Cohen F.E., Vandlen R., Henner D., Prusiner S.B. High-Level Expression and Characterization of a Purified 142-Residue Polypeptide of the Prion Protein. Biochemistry 1996, 35(17):5528-5537.
28. Sanghera N., Pinheiro T.J.T. Binding of Prion Protein to Lipid Membranes and Implications for Irion Conversion. J. Mol. Biol 2002, 315(5):1241-1256.
29. Martins S.M., Frosoni D.J., Martinez A.M., De Felice F.G., Ferreira S.T. Formation of Soluble Oligomers and Amyloid Fibrils with Physical Properties of the Scrapie Isoform of the Prion Protein from the C-Terminal Domain of Recombinant Murine Prion Protein mPrP-(121-231). J. Biol. Chem 2006, 281(36):26121-26128.
30. Goormaghtigh E., Cabiaux V., Ruysschaert J.M. Secondary Structure and Dosage of Soluble and Membrane Proteins by Attenuated Total Reflection Fourier-Transform Infrared Spectroscopy on Hydrated Films. Eur. J. Biochem 1990, 193(2):409-420.
31. Gidden J., Ferzoco A., Baker E.S., Bowers M.T. J. Am. Chem. Soc 2004, 126:15132.
32. Wildgoose J.L., Giles K., Pringle S.D., Koeniger S.J., Valentine R.H., Bateman R.H., Clemmer D.E. 2005.
33. Scarff C.A., Thalassinos K., Hilton G.R., Scrivens J.H. Traveling Wave Ion Mobility Mass Spectrometry Studies of Protein Structure: Biological Significance and Comparison with X-ray Crystallography and Nuclear Magnetic Resonance Spectroscopy Measurements. Rapid Commun. Mass Spectrom 2008, 22(20):3297-3304.
34. Ruotolo B.T., Giles K., Campuzano I., Sandercock A.M., Bateman R.H., Robinson C.V. Evidence for Macromolecular Protein Rings in the Absence of Bulk Water. Science 2005, 310(5754):1658-1661.
35. Scrivens J.H., Thalassinos K., Hilton G.R., Slade S.E., Pinheiro T.J.T., Bateman R.H., Bowers M.T. 2006.
36. Ruotolo B.T., Benesch J.L., Sandercock A.M., Hyung S.J., Robinson C.V. Ion Mobility-Mass Spectrometry Analysis of Large Protein Complexes. Nat. Protoc 2008, 3(7):1139-1152.
37. Clemmer D.E. http://www.indiana.edu/~clemmer/.
38. Mesleh M.F., Hunter J.M., Shvartsburg A.A., Schatz G.C., Jarrold M.F. Structural Information from Ion Mobility Measurements: Effects of the Long-Range Potential. J. Phys. Chem 1996, 100(40):16082-16086.
39. Caughey B., Race R.E., Ernst D., Buchmeier M.J., Chesebro B. Prion Protein Biosynthesis in Scrapie-Infected and Uninfected Neuroblastoma Cells. J. Virol 1989, 63(1):175-181.
40. Borchelt D.R., Scott M., Taraboulos A., Stahl N., Prusiner S.B. Scrapie and Cellular Prion Proteins Differ in Their Kinetics of Synthesis and Topology in Cultured Cells. J. Cell. Biol 1990, 110(3):743-752.
41. Caughey B., Raymond G.J. The Scrapie-Associated Form of PrP Is Made from a Cell Surface Precursor That Is Both Protease- and Phospholipase-Sensitive. J. Biol. Chem 1991, 266(27):18217-18223.
42. Yedidia Y., Horonchik L., Tzaban S., Yanai A., Taraboulos A. Proteasomes and Ubiquitin Are Involved in the Turnover of the Wild-Type Prion Protein. EMBO J 2001, 20(19):5383-5391.
43. Hosszu L.L., Trevitt C.R., Jones S., Batchelor M., Scott D.J., Jackson G.S., Collinge J., Waltho J.P., Clarke A.R. Conformational Properties of {beta}-PrP. J. Biol. Chem 2009, 284(33):21981-21990.
44. Li J., Browning S., Mahal S.P., Oelschlegel A.M., Weissmann C. Darwinian Evolution of Prions in Cell Culture. Science 2009, 869-872.
45. Gambetti P., Dong Z., Yuan J., Xiao X., Zheng M., Alshekhlee A., Castellani R., Cohen M., Barria M.A., Gonzalez-Romero D., Belay E.D., Schonberger L.B., Marder K., Harris C., Burke J.R., Montine T., Wisniewski T., Dickson D.W., Soto C., Hulette C.M., Mastrianni J.A., Kong Q., Zou W.Q. A Novel Human Disease with Abnormal Prion Protein Sensitive to Protease. Ann. Neurol 2008, 63(6):697-708.
46. Castilla J., Saa P., Hetz C., Soto C. In Vitro Generation of Infectious Scrapie Prions. Cell 2005, 121(2):195-206.
47. Grabenauer M., Sanghera N., Pinheiro T.J., Scrivens J.H., Bowers M.T. Conformational Stability of Syrian Hamster Prion Protein PrP(90-231) 2009, unpublished, (submitted).
48. Badman E.R., Myung S., Clemmer D.E. Evidence for Unfolding and Refolding of Gas-Phase Cytochrome c Ions in a Paul Trap. J. Am. Soc. Mass Spectrom 2005, 16(9):1493-1497.
49. Wyttenbach T., Grabenauer M., Thalassinos K., Scrivens J.H., Bowers M.T. The Effect of Calcium Ions and Peptide Ligands on the Stability of the Calmodulin Dumbbell Structure 2009, unpublished, (submitted).
50. Caughey B. Cellular Metabolism of Normal and Scrapie-Associated Forms of PrP. Semin. Virol 1991, 2:189-196.
51. Weissmann C. Molecular Genetics of Transmissible Spongiform Encephalopathies. J. Biol. Chem 1999, 274(1):3-6.